Quality standards are the framework that turns a vague claim like "high purity" into something measurable, comparable, and verifiable. For research peptides, several standards bodies and frameworks apply — sometimes overlapping, sometimes not. This guide maps the alphabet soup to what actually matters at the bench.
USP (United States Pharmacopeia)
USP publishes binding pharmaceutical-quality standards. For peptides, the relevant chapters include:
- USP <71> — Sterility testing.
- USP <85> — Bacterial endotoxin testing (BET) by LAL.
- USP <232> / <233> — Elemental impurities (heavy metals).
- USP <1057> — Biotechnology-derived articles, including peptide identity.
- USP <1226> — Verification of compendial procedures.
For research peptides, USP-aligned testing (even when the peptide isn't itself a USP article) is a strong quality signal. It means the supplier or their lab has chosen recognized methods over ad-hoc ones.
EP (European Pharmacopoeia)
The European equivalent of USP. EP and USP are highly harmonized for peptide-relevant tests. A supplier producing for both U.S. and European research markets will often cite both standards.
ICH (International Council for Harmonisation)
ICH publishes guidelines that harmonize pharmaceutical regulation across the U.S., EU, and Japan. For peptides, the most relevant include:
- ICH Q1A–Q1F — Stability testing (how shelf life is established).
- ICH Q2(R1) — Validation of analytical procedures.
- ICH Q3A/B — Impurities in new drug substances and products.
- ICH Q3D — Elemental impurities.
- ICH Q6A/B — Specifications for new drug substances and biotechnological products.
ICH guidelines are technical, not legal — but compliance is the global expectation for high-quality manufacturing.
ISO/IEC 17025
The international standard for the competence of testing and calibration laboratories. When a third-party lab is ISO 17025 accredited, it has demonstrated to an external auditor that:
- Methods are validated.
- Equipment is calibrated to traceable standards.
- Personnel are qualified.
- Quality management systems are in place.
- Results are statistically defensible.
For peptide COAs, an ISO 17025 lab signature is one of the strongest verification signals available.
cGMP (current Good Manufacturing Practice)
cGMP is a regulatory framework — in the U.S., enforced by the FDA — that governs how pharmaceutical and biotech products are manufactured. It covers facility design, personnel training, raw material controls, in-process testing, batch records, change control, deviation investigation, and more.
Most research peptides are not manufactured under full cGMP because they're sold as research-use-only materials, not pharmaceutical products. However, suppliers that adopt GMP-aligned practices (controlled environments, batch documentation, change control) provide higher consistency and defensibility than those that don't.
RUO (Research Use Only)
RUO is a regulatory designation meaning the product is intended for in vitro and laboratory research and is not for human or veterinary use. RUO products do not require FDA approval, GMP manufacturing, or clinical safety testing. The label is a legal shield — not a quality statement. RUO products span the full quality spectrum from rigorous third-party-tested research material to low-quality sketchy product.
RUO tells you what the product is intended for. The COA tells you what's in the vial. They are different questions.
How to evaluate a supplier's quality posture
Look for documented evidence in the following areas:
- Standards-aligned testing — does the supplier cite USP, EP, ICH, or equivalent methods?
- Third-party verification — are COAs issued by ISO 17025 accredited labs, or in-house?
- Test breadth — do COAs cover purity, identity, sterility, endotoxin, and heavy metals — or only purity?
- Batch traceability — can you match a vial in your hand to a specific COA by lot number?
- Stability data — does the supplier publish shelf-life claims backed by ICH Q1A-aligned stability testing, or just guesses?
- Document availability — are COAs and SDSs publicly browsable, or only available on request?
Common quality red flags
- "Pharmaceutical grade" without a corresponding GMP claim or audit reference.
- Purity figures with no chromatograms or analytical lab name.
- No batch numbers, or batch numbers that don't match shipped vials.
- Only one quality metric reported (typically just HPLC purity).
- Unwillingness to disclose the analytical lab.
- Stability claims without underlying study data.
Does a peptide need to be GMP-grade to be high-quality?
No — most research peptides are RUO and are not produced under full GMP. Quality is determined by analytical testing breadth, third-party verification, and consistent process control rather than GMP status alone.
What's the difference between USP-grade and research-use peptides?
USP-grade peptides meet the specific testing and identity requirements in the USP monograph for that compound (when one exists). Research-grade peptides may use USP methods but aren't formally certified to USP monograph compliance. Most research peptides are research-use.
How can I tell if a third-party testing lab is legitimate?
Check for ISO 17025 accreditation through national accreditation bodies (A2LA in the U.S., UKAS in the UK, DAkkS in Germany). Accreditation is searchable online. The lab should be willing to confirm a specific COA's legitimacy if you call.
Our quality posture
American Peptides batches are tested using USP-aligned methods, with COAs issued by accredited third-party laboratories covering purity, identity, sterility, endotoxin, and heavy metals. Every batch number is traceable to a published COA. Browse the library or read about why third-party testing matters.
Compliance Notice: American Peptides products are sold strictly for laboratory and academic research purposes only. They are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease. All content on this page is educational in nature and does not constitute medical advice or product claims. Researchers are responsible for handling these compounds in accordance with their institutions safety protocols and applicable laws.
